SERA - Sera Prognostics Inc - Ordinary Shares Class A
IEX Last Trade
7.35
0.360 4.898%
Share volume: 51,536
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$6.99
0.36
5.15%
View ratios
Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2022-08-10 | 2022-11-09 | 2023-03-22 | 2023-05-10 | 2023-08-09 | 2023-11-08 | 2024-03-20 | 2024-05-08 | |
Total revenue | 78.000 K | 87.000 K | 65.000 K | 100.000 K | 123.000 K | 42.000 K | 41.000 K | 0.000 | |
Cost of revenue | 56.000 K | 58.000 K | 59.000 K | 62.000 K | 80.000 K | 44.000 K | 24.000 K | 17.000 K | |
Gross profit | 22.000 K | 29.000 K | 6.000 K | 38.000 K | 43.000 K | -2.000 K | 17.000 K | -17.000 K | |
31.82% | -79.31% | 533.33% | 13.16% | -104.65% | 950.00% | -200.00% | |||
Operating expenses | 11.768 M | 11.217 M | 10.424 M | 11.367 M | 11.503 M | 8.182 M | 8.865 M | 9.080 M | |
Selling general and admin | 8.507 M | 7.041 M | 6.939 M | 7.264 M | 7.815 M | 4.643 M | 4.970 M | 5.397 M | |
Research and development | 3.261 M | 4.176 M | 3.485 M | 4.103 M | 3.688 M | 3.539 M | 3.895 M | 3.683 M | |
Total expenses | 11.824 M | 11.275 M | 10.483 M | 11.429 M | 11.583 M | 8.226 M | 8.889 M | 9.097 M | |
-4.64% | -7.02% | 9.02% | 1.35% | -28.98% | 8.06% | 2.34% | |||
Operating income | -11.746 M | -11.188 M | -10.418 M | -11.329 M | -11.460 M | -8.184 M | -8.848 M | -9.097 M | |
Ebit | -11.746 M | -11.188 M | -10.418 M | -11.329 M | -11.460 M | -8.184 M | -8.848 M | -9.097 M | |
Pretax income | -11.520 M | -10.712 M | -9.746 M | -10.565 M | -10.542 M | -7.210 M | -7.925 M | -8.097 M | |
-7.01% | -9.02% | 8.40% | -0.22% | -31.61% | 9.92% | 2.17% | |||
Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Net income basic | -11.520 M | -10.712 M | -9.746 M | -10.565 M | -10.542 M | -7.210 M | -7.925 M | -8.097 M | |
7.01% | 9.02% | -8.40% | 0.22% | 31.61% | -9.92% | -2.17% | |||
Net income | -11.520 M | -10.712 M | -9.746 M | -10.565 M | -10.542 M | -7.210 M | -7.925 M | -8.097 M | |
7.01% | 9.02% | -8.40% | 0.22% | 31.61% | -9.92% | -2.17% |